Routine bacterial screening of platelet concentrates by flow cytometry and its impact on product safety and supply

Vox Sanguinis

Volumn 108, Issue 3, 2015, Pages 209-218

  Muller B ^a   Walther Wenke, G ^b   Kalus, M ^c   Alt, T ^c   Bux, J ^a   Zeiler, T ^d   Schottstedt, V ^a  

^a Central Lab   (Germany)

^b GRC West Blood Donation Service   (Germany)

^c German Red Cross Blood Donation Service West   (Germany)

^d GRC West Blood Donation Service   (Germany)

Author keywords

Bacterial contamination; Blood donation testing; Platelet concentrates

Indexed keywords

THROMBOCYTE CONCENTRATE;

ARTICLE; BACILLUS CEREUS; BACTERIA; BACTERIAL SCREENING; BACTERIAL STRAIN; BACTERIUM CONTAMINATION; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE POSITIVE RESULT; FLOW CYTOMETER; FLOW CYTOMETRY; GOLD STANDARD; HUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; PRODUCT SAFETY; SCREENING TEST; SHELF LIFE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS DYSGALACTIAE SUBSP. EQUISIMILIS; BLOOD SAFETY; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROCEDURES; THROMBOCYTE;

BLOOD PLATELETS; BLOOD SAFETY; FLOW CYTOMETRY; HUMANS; STAPHYLOCOCCUS AUREUS;

EID: 84924700305     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12214     Document Type: Article

References (45)

1. Brecher ME, Blajchman MA, Yomtovian R, et al.: Addressing the risk of bacterial contamination of platelets within the United States: a history to help illuminate the future. Transfusion 2013; 53:221-231
2. Brecher ME, Hay SN: Bacterial contamination of blood components. Clin Microbiol Rev 2005; 18:195-204
3. Fatalities reported to FDA following blood collection and transfusion. Annual summary for fiscal year 2011. Available from: Access date: 30 October 2014.
4. Montag T: Strategies of bacteria screening in cellular blood components. Clin Chem Lab Med 2008; 46:926-932
5. Schrezenmeier H, Walther-Wenke G, Müller TH, et al.: Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion 2007; 47:644-652
6. Agence nationale de sécurité du médicament et des produits des santé. French international report. Available from: Acess date: 30 October 2014.
7. Lohmann A, Halbauer J, Witzenhausen C, et al.: Hemovigilance Report of the Paul-Ehrlich-Institut 2012. Available from: Acess date: 30 October 2014.
8. Montag T: Perspectives and limitations in the bacterial screening of platelet concentrates. J Lab Med 2006; 30:60-65
9. Palavecino EL, Yomtovian RA, Jacobs MR: Bacterial contamination of platelets. Transfus Apheres Sci 2010; 42:71-82
10. de Korte D, Curvers J, de Kort WL, et al.: Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands. Transfusion 2006; 46:476-485
11. Dreier J, Störmer M, Pichl L, et al.: Sterility screening of platelet concentrates: questioning the optimal test strategy. Vox Sang 2008; 95:181-188
12. Eder AF, Kennedy JM, Dy BA, et al.: Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion 2007; 47:1134-1142
13. Fang CT, Chambers LA, Kennedy J, et al.: Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004. Transfusion 2005; 45:1845-1852
14. Larsen CP, Ezligini F, Hermansen NO, et al.: Six years' experience of using the BacT/ALERT system to screen all platelet concentrates, and additional testing of outdated platelet concentrates to estimate the frequency of false-negative results. Vox Sang 2005; 88:93-97
15. Ramirez-Arcos S, Jenkins C, Dion J, et al.: Canadian experience with detection of bacterial contamination in apheresis platelets. Transfusion 2007; 47:421-429
16. te Boekhorst PA, Beckers EA, Vos MC, et al.: Clinical significance of bacteriologic screening in platelet concentrates. Transfusion 2005; 45:514-519
17. Blut A: Votum 38: Festlegung der Haltbarkeitsfrist vom Thrombozytenkonzentraten mit dem Ziel der Reduktion lebensbedrohlicher septischer Transfusionsreaktionen durch bakterielle Kontaminationen. Bundesgesundheitsblatt 2008; 51:1484
18. Funk M, Günay S, Lohmann A: Hämovigilanzbericht des Paul-Ehrlich-Instituts, 2014, Access date: 30 October 2014.
19. Störmer M, Vollmer T: Diagnostic methods for platelet bacteria screening: current status and developments. Transfus Med Hemother 2014; 41:19-27
20. Walther-Wenke G, Daubener W, Heiden M, et al.: Effect of safety measures on bacterial contamination rates of blood components in Germany. Transfus Med Hemother 2011; 38:231-235
21. Eder AF, Dy BA, Barton J, et al.: The American Red Cross Hemovigilance Program: advancing the safety of blood donation and transfusion. Immunohematology/American Red Cross 2009; 25:179-185
22. Borosak M, Wood E: Bacterial pre-release testing of platelets - the Australian Red Cross Blood Service clinical experience. Transfus Med Hemother 2011; 38:239-241
23. Fuller AK, Uglik KM, Savage WJ, et al.: Bacterial culture reduces but does not eliminate the risk of septic transfusion reactions to single-donor platelets. Transfusion 2009; 49:2588-2593
24. Jenkins C, Ramirez-Arcos S, Goldman M, et al.: Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk. Transfusion 2011; 51:2555-2565
25. Dumont LJ, Kleinman S, Murphy JR, et al.: Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results. Transfusion 2010; 50:589-599
26. Murphy WG, Foley M, Doherty C, et al.: Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sang 2008; 95:13-19
27. Pearce S, Rowe GP, Field SP: Screening of platelets for bacterial contamination at the Welsh Blood Service. Transfus Med 2011; 21:25-32
28. Mohammadi T, Savelkoul PH, Pietersz RN, et al.: Applications of real-time PCR in the screening of platelet concentrates for bacterial contamination. Expert Rev Mol Diagn 2006; 6:865-872
29. Rood IG, Koppelman MH, Pettersson A, et al.: Development of an internally controlled PCR assay for broad range detection of bacteria in platelet concentrates. J Microbiol Methods 2008; 75:64-69
30. Zweitzig DR, Riccardello NM, Pester JM, et al.: A novel approach for rapid detection of bacterially contaminated platelet concentrates via sensitive measurement of microbial DNA polymerase activity. Transfusion 2013; 54:1642-1651.
31. Zweitzig DR, Riccardello NM, Sodowich BI, et al.: Characterization of a novel DNA polymerase activity assay enabling sensitive, quantitative and universal detection of viable microbes. Nucleic Acids Res 2012; 40:e109
32. Karo O, Wahl A, Nicol SB, et al.: Bacteria detection by flow cytometry. Clin Chem Lab Med 2008; 46:947-953
33. Mohr H, Lambrecht B, Bayer A, et al.: Basics of flow cytometry-based sterility testing of platelet concentrates. Transfusion 2006; 46:41-49
34. Schmidt M, Hourfar MK, Nicol SB, et al.: FACS technology used in a new rapid bacterial detection method. Transfus Med 2006; 16:355-361
35. Schmidt M, Karakassopoulos A, Burkhart J, et al.: Comparison of three bacterial detection methods under routine conditions. Vox Sang 2007; 92:15-21
36. Vollmer T, Engemann J, Kleesiek K, et al.: Bacterial screening by flow cytometry offers potential for extension of platelet storage: results of 14 months of active surveillance. Transfus Med 2011; 21:175-182
37. Dreier J, Vollmer T, Kleesiek K: Novel flow cytometry-based screening for bacterial contamination of donor platelet preparations compared with other rapid screening methods. Clin Chem 2009; 55:1492-1502
38. Vollmer T, Schottstedt V, Bux J, et al.: Bacterial screening of platelet concentrates on day 2 and 3 with flow cytometry: the optimal sampling time point? Blood Transfus 2014; 12:388-395
39. Jacobs MR, Good CE, Lazarus HM, et al.: Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets. Clin Infect Dis 2008; 46:1214-1220
40. Jacobs MR, Smith D, Heaton WA, et al.: Detection of bacterial contamination in prestorage culture-negative apheresis platelets on day of issue with the Pan Genera Detection test. Transfusion 2011; 51:2573-2582
41. Vollmer T, Dreier J, Schottstedt V, et al.: Detection of bacterial contamination in platelet concentrates by a sensitive flow cytometric assay (BactiFlow): a multicentre validation study. Transfus Med 2012; 22:262-271
42. Störmer M, Kleesiek K, Dreier J: Propionibacterium acnes lacks the capability to proliferate in platelet concentrates. Vox Sang 2008; 94:193-201
43. Liu PY, Huang YF, Tang CW, et al.: Staphylococcus lugdunensis infective endocarditis: a literature review and analysis of risk factors. J Microbiol Immunol Infect 2010; 43:478-484
44. Babu E, Oropello J: Staphylococcus lugdunensis: the coagulase-negative staphylococcus you don't want to ignore. Expert Rev Anti Infect Ther 2011; 9:901-907
45. Vollmer T, Hinse D, Schottstedt V, et al.: Inter-laboratory comparison of different rapid methods for the detection of bacterial contamination in platelet concentrates. Vox Sang 2012; 103:1-9